These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9132869)

  • 1. [Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
    Laguna F; Valencia E; Polo R; Moreno V; González-Lahoz JM
    Rev Clin Esp; 1996 Dec; 196(12):878-9. PubMed ID: 9132869
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluconazole-resistant pseudomembranous oral candidiasis.
    Shetty K
    Ann Pharmacother; 2006 May; 40(5):993. PubMed ID: 16638917
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
    Fortun Abete J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
    Jandourek A; Vaishampayan JK; Vazquez JA
    AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy.
    Valdez H; Gripshover BM; Salata RA; Lederman MM
    AIDS; 1998 Mar; 12(5):538. PubMed ID: 9543458
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
    Hegener P; Troke PF; Fätkenheuer G; Diehl V; Ruhnke M
    AIDS; 1998 Nov; 12(16):2227-8. PubMed ID: 9833866
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluconazole prophylaxis in HIV disease, revisited.
    Bozzette SA
    Clin Infect Dis; 2005 Nov; 41(10):1481-2. PubMed ID: 16231261
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Candida humicola infection of the central nervous system in an HIV-infected patient: a case report].
    Rogowska-Szadkowska D; Wiercińska-Drapało A; Borzuchowska A; Prokopowicz D
    Przegl Epidemiol; 1997; 51(4):465-9. PubMed ID: 9562797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
    Vuffray A; Durussel C; Boerlin P; Boerlin-Petzold F; Bille J; Glauser MP; Chave JP
    AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555
    [No Abstract]   [Full Text] [Related]  

  • 12. No resistance to fluconazole with short-term treatment for oral thursh.
    AIDS Patient Care STDS; 1996 Dec; 10(6):379. PubMed ID: 11361570
    [No Abstract]   [Full Text] [Related]  

  • 13. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
    Oude Lashof AM; De Bock R; Herbrecht R; de Pauw BE; Krcmery V; Aoun M; Akova M; Cohen J; Siffnerová H; Egyed M; Ellis M; Marinus A; Sylvester R; Kullberg BJ;
    Eur J Cancer; 2004 Jun; 40(9):1314-9. PubMed ID: 15177489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
    Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
    Migliorati CA; Birman EG; Cury AE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):301-10. PubMed ID: 15356467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal infection overview.
    Treat Rev; 1995 May; (no 18):10. PubMed ID: 11362589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
    AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
    Taillandier J; Esnault Y; Alemanni M
    Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole and fluconazole in oropharyngeal candidiasis.
    van der Bijl P; Arendorf TM
    Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.